Patent pools for generic drugs

Mark Schankerman interviewed by Tim Phillips, 19 February 2021

Diffusion of new drugs is painfully slow in low-income countries. Mark Schankerman tells Tim Phillips about how patent pools accelerate the process, and how we could still do a better job of licensing life-saving medicines.

a

A

Related

Topics:  Competition policy Covid-19 Health economics

Tags:  procurement, medicine, COVID-19

Mark Schankerman

Professor of Economics, London School of Economics and CEPR Research Fellow

Don't Miss

Shaping Africa’s post-Covid recovery: A new eBook
Arezki, Djankov, Panizza
Stronger together? The policy mix strikes back
Bartsch, Bénassy-Quéré, Corsetti, Debrun
Taxing the superrich
Scheuer

CEPR Policy Research